Related Experiment Video
Updated: Jun 9, 2025

Real-Time Dynamic Navigation System for the Precise Quad-Zygomatic Implant Placement in a Patient with a Severely Atrophic Maxilla
Published on: October 18, 2021
Venous Thromboembolism Prophylaxis in Maxillofacial Surgery.
Inês Camelo1, Flávia Pereira1, Mariana Cebotari1
1Maxillofacial Surgery Department, Centro Hospitalar Universitário de São João, Porto, PRT.
Patients undergoing maxillofacial surgery generally have a low risk of venous thromboembolism (VTE). Prophylaxis should be individualized, with pharmacological options considered for high-risk patients (Caprini score ≥7).
Area of Science:
- Oral and Maxillofacial Surgery
- Vascular Surgery
- Anesthesiology
Background:
- Venous thromboembolism (VTE) is a significant concern in surgical patients.
- Maxillofacial surgery patients represent a unique demographic with potentially varying VTE risks.
- Current guidelines for VTE prophylaxis may not be fully established for this specific surgical population.
Purpose of the Study:
- To review the existing literature on the necessity of VTE prophylaxis in maxillofacial surgery.
- To explore VTE diagnosis, risk stratification, and appropriate prophylactic measures for these patients.
Main Methods:
- A literature search was conducted to identify relevant studies.
- Nine articles were selected based on their pertinence to VTE prophylaxis in maxillofacial surgery.
- Data regarding VTE risk, diagnosis, and prevention were synthesized.
Main Results:
- Evidence suggests that patients undergoing maxillofacial surgery generally present a low risk of VTE.
- Individualized risk assessment is crucial for determining the need for prophylaxis.
- Pharmacological prophylaxis may be beneficial for patients with a high-risk score (Caprini score ≥7).
Conclusions:
- While VTE risk in maxillofacial surgery appears low, tailored prophylactic strategies are important.
- Further research is required to refine and optimize VTE prevention protocols for this patient group.
- Personalized risk assessment, including the Caprini score, should guide prophylactic decisions.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Tonsillitis II: Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

